Reports:
Office of Evaluation and Inspections Reports
Subject Index: D
Return to OEI Reports Subject Index
| Topics: | ||
|---|---|---|
All documents on this page are PDF.
Adobe® Acrobat® 
is required to read PDF files.
Data Banks/Data Systems
- see also: National Practitioner Data Bank
- Results-Based Systems for Public Health Programs, Volume 1: Lessons from State Initiatives (OEI-05-96-00260; 9/97)
- Results-Based Systems for Public Health Programs, Volume 2: State Case Studies (OEI-05-96-00261; 9/97)
- Surveillance and Utilization Review Subsystem Referrals (OEI-07-95-00030; 11/96)
- Implementation of State Child Support Certified Data Systems (OEI-04-96-00010; 4/97)
Dental and Dentists
- Improper Payments for Medicaid Pediatric Dental Services (OEI-04-04-00210)
- Children's Dental Services Under Medicaid: Access and Utilization (OEI-09-93-00240; 4/96)
- The Licensure of Out-of-State Dentists (OEI-01-92-00820; 8/93)
- State Dental Boards and Dental Discipline (OEI-01-92-00821; 8/93)
- State Licensure and Discipline of Dentists (OAI-01-88-00580; 8/88)
Detoxification Services
- see also: Substance Abuse
- Follow-up to Detoxification Services for Medicaid Beneficiaries (OEI-07-97-00270; 11/98)
Devices
Diagnosis Related Groups (DRGs)
- Medicare Hospital Prospective Payment System: How DRG Rates Are Calculated and Updated (OEI-09-00-00200; 08/01)
- Medicare Payments for DRG 014: Specific Cerebrovascular Disorders Except Transient Ischemic Attack (OEI-03-99-00240; 7/99)
- Medicare Payments for DRG 296: Nutritional and Miscellaneous Metabolic Disorders (OEI-03-98-00490; 4/99)
- Medicare Payments for Septicemia (OEI-03-98-00370; 4/99)
- Medicare Payments for DRG 475: Respiratory System Diagnosis with Ventilator Support (OEI- 03-98-00560; 1/99)
- Monitoring the Accuracy of Hospital Coding (OEI-01-98-00420; 1/99)
- Using Software to Detect Upcoding of Hospital Bills (OEI-01-97-00010; 8/98)
- DRG 79 Validation Study Update: Respiratory Infections and Inflammations (OEI-12-89-00193; 9/93)
- DRG 154 Validation: Stomach, Esophageal, and Duodenal (OEI-12-89-00196; 12/93)
- DRG 121 Validation: Circulatory Disorders (OEI-12-89-00194; 10/92)
- DRG 296 Validation: Metabolic Disorders (OEI-12-89-00195; 10/92)
- National DRG Validation Study Update: Summary Report (OEI-12-89-00190; 8/92)
- National DRG Validation Study Update: Technical Report (OEI-12-89-00191; 8/92)
- DRG 14 Validation Update: Specific Cerebrovascular Disorders Except Transient Ischemic Attacks (OEI-12-89-00192; 8/92)
- FY 1985 National DRG Validation Study: Peer Review Organization Coding Accuracy (OEI-12-90-00660; 8/90)
- DRG 468: Unrelated Operating Room Procedures (OAI-12-88-01170; 9/89)
- DRG 79: Respiratory Infection (OAI-12-88-01190; 7/89)
- National DRG Validation Study: Quality of Patient Care in Hospitals (OAI-09-88-00870; 8/89)
- DRG 87: Pulmonary Edema and Respiratory Failure (OAI-12-88-01200; 8/89)
- DRG 121: Circulatory Disorders with Acute Myocardial Infarction and Cardiovascular Complications (OAI-12-88-01210; 8/89)
- DRG 154: Stomach, Esophageal, and Duodenal Procedures (OAI-12-88-01160; 8/89)
- DRG 416: Septicemia (OAI-12-88-01180; 8/89)
- DRG 89: Simple Pneumonia and Pleurisy (OAI-12-88-01140; 6/89)
- National DRG Validation Study: Short Hospitalizations (OAI-05-88-00730; 5/89)
- National DRG Validation Study: Unnecessary Admissions to Hospitals (OAI-09-88-00880; 8/88)
- National DRG Validation Study: Coding Accuracy (OAI-12-88-01010; 2/88)
- National DRG Validation Study: Premature Discharges (OAI-05-88-00740; 2/88)
- Validation of DRG 14 (OAI-09-86-00052; 12/87)
Dialysis and Dialysis Facilities
Dietary Supplements
- Dietary Supplement Labels: Key Elements (OEI-01-01-00120; 03/03)
- Dietary Supplement Labels: An Assessment (OEI-01-01-00121; 03/03)
- Adverse Event Reporting System for Dietary Supplements: An Inadequate Safety Valve (OEI-01-00-00180; 04/01)
Disability
- Employment Programs for Persons with Developmental Disabilities (OEI-07-98-00260; 8/99)
- Perspectives of Medicare Risk HMOs 1996: Beneficiaries With Functional Limitations, Comorbidities and Disabilities (OEI-06-95-00434; 8/98)
- Cost Containment for Medicaid Disability Programs (OEI-05-95-00400; 7/97)
- Using Social Security Records to Detect Inappropriate Medicare Payments for Work-Related Disability Expenses (OEI-06-89-00903; 8/94)
- Propriety of Physicians' Receipt of Federal Payments (OAI-06-86-00067; 10/86)
Disaster Relief
- Coping With Twin Disasters: HHS Response to the 1989 Hurricane and Earthquake (OEI-09-90-01040; 12/90)
Discharge
- see: Dumping
Discretionary Grants
- Time Extensions and Funding Supplements for OHDS Discretionary Grants (OEI-04-89-00801; 6/92)
Drug Abuse
- see: Substance Abuse
Drug Enforcement Administration (DEA)
- Drug Enforcement Administration Report to the National Practitioner Data Bank (OEI-12-96-00160; 3/97)
Drugs and Drug Industry
- Comparison of First-Quarter 2008 Average Sales Prices and Average Manufacturer Prices: Impact on Medicare Reimbursement for Third Quarter 2008 (OEI-03-08-00530)
- Comparison of Average Sales Prices and Average Manufacturer Prices: An Overview of 2007 (OEI-03-08-00450)
- Comparing Special Needs Plan Beneficiaries to Other Medicare Advantage Prescription Drug Plan Beneficiaries (OEI-05-07-00490)
- Centers for Medicare & Medicaid Services Audits of Medicare Part D Bids (OEI-05-07-00560)
- Oversight of Prescription Drug Plan Sponsors’ Compliance Plans (OEI-03-08-00230)
- Medicare Drug Plan Sponsors’ Identification of Potential Fraud and Abuse (OEI-03-07-0380)
- Medicare Payment for Irinotecan (OEI-03-08-00310)
- Comparison of Fourth-Quarter 2007 Average Sales Prices and Average Manufacturer Prices: Impact on Medicare Reimbursement for Second-Quarter 2008 (OEI-03-08-00340)
- A Comparison of Average Sales Prices to Widely Available Market Prices for Inhalation Drugs (OEI-03-07-00190)
- Comparison of Third-Quarter 2007 Average Sales Prices to Average Manufacturer Prices: Impact on Medicare Reimbursement for First-Quarter 2008 (OEI-03-08-00130)
- Comparison of Second-Quarter 2007 Average Sales Prices and Average Manufacturer Prices: Impact on Medicare Reimbursement for Fourth Quarter 2007 (OEI-03-08-00010)
- Generic Drug Utilization in the Medicare Part D Program (OEI-05-07-00130)
- Comparison of First-Quarter 2007 Average Sales Prices to Average Manufacturer Prices: Impact on Medicare Reimbursement for Third Quarter 2007 (OEI-03-07-00530)
- Comparison of Third-Quarter 2006 Average Sales Prices to Average Manufacturer Prices: Impact on Medicare Reimbursement for First Quarter 2007 (OEI-03-07-00140)
- Retail Pharmacy Participation in Medicare Part D Prescription Drug Plans in 2006 (OEI-05-06-00320)
- Deficit Reduction Act of 2005: Impact on the Medicaid Federal Upper Limit Program (OEI-03-06-00400)
- Examining Fluctuations in Average Manufacturer Prices (OEI-03-06-00350)
- States’ Use of New Drug Pricing Data in the Medicaid Program (OEI-03-06-00490)
- Intravenous Immune Globulin: Medicare Payment and Availability (OEI-03-05-00404)
- Comparison of Fourth Quarter 2005 Average Sales Prices to Average Manufacturer Prices: Impact on Medicare Reimbursement for Second Quarter 2006 (OEI-03-06-00370; 07/06)
- Review of 340B Prices (OEI-05-02-00073; 07/06)
- Generic Drug Utilization in State Medicaid Programs (OEI-05-05-00360; 07/06)
- A Comparison of Average Sales Price to Widely Available Market Prices: Fourth Quarter 2005 (OEI-03-05-00430; 06/06)
- Monitoring Medicare Part B Drug Prices: A Comparison of Average Sales Prices to Average Manufacturer Prices (OEI-03-04-00430; 05/06)
- Medicare Reimbursement for New End Stage Renal Disease Drugs (OEI-03-06-00200; 03/06)
- Calculation of Volume-Weighted Average Sales Price for Medicare Part B Prescription Drugs (OEI-03-05-00310; 03/06)
- Deficiencies in the Oversight of the 340B Drug Pricing Program (OEI-05-02-00072; 10/05)
- Review of Services Provided by Inhalation Drug Suppliers (OEI-01-05-00090; 09/05)
- How Inflated Published Prices Affect Drugs Considered for the Federal Upper Limit List (OEI-03-05-00350; 09/05)
- Comparison of Medicaid Federal Upper Limit Amounts to Average Manufacturer Prices (OEI-03-05-00110; 06/05)
- Medicaid Drug Price Comparisons: Average Manufacturer Price to Published Prices (OEI-05-05-00240; 06/05)
- Medicaid Drug Price Comparison: Average Sale Price to Average Wholesale Price (OEI-03-05-00200; 06/05)
- Addition of Qualified Drugs to the Medicaid Federal Upper Limit List (OEI-03-04-00320; 12/04)
- Variation in State Medicaid Drug Prices (OEI-05-02-00681; 09/04)
- Deficiencies in the 340B Drug Discount Program's Database (OEI-05-02-00071; 06/04)
- Appropriateness of 340B Drug Prices (OEI-05-02-00070; 06/04)
- Medicare Reimbursement for Existing End-Stage Renal Disease Drugs (OEI-03-04-00120; 05/04)
- Medicaid Rebates for Physician-Administered Drugs (OEI-03-02-00660; 04/04)
- Omission of Drugs from the Federal Upper Limit List in 2001 (OEI-03-02-00670; 03/04)
- Medicare Reimbursement for Lupron (OEI-03-03-00250; 01/04)
- Update: Excessive Medicare Reimbursement for Albuterol (OEI-03-03-00510; 01/04)
- Update: Excessive Medicare Reimbursement for Ipratropium Bromide (OEI-03-03-00520; 01/04)
- State Strategies to Contain Medicaid Drug Costs (OEI-05-02-00680)
- Medicaid's Mental Health Drug Expenditures (OEI-05-02-00080; 08/03)
- FDA's Review Process for New Drug Applications: A Management Review (OEI-01-01-00590; 03/02)
- Excessive Medicare Reimbursement for Ipratropium Bromide (OEI-03-01-00411; 03/02)
- Psychotropic Drug Use in Nursing Homes (OEI-02-00-00490; 11/01)
- Psychotropic Drug Use in Nursing Homes: Supplemental Information–10 Case Studies (OEI-02-00-00491; 11/01)
- Medicaid's Use of Revised Average Wholesale Prices (OEI-03-01-00010; 10/01)
- Medicaid Recovery of Pharmacy Payments from Liable Third Parties (OEI-03-00-00030; 08/01)
- Cost Containment of Medicaid HIV/AIDS Drug Expenditures (OEI-05-99-00611; 07/01)
- The Orphan Drug Act: Implementation and Impact (OEI-09-00-00380; 05/01)
- Adverse Event Reporting System for Dietary Supplements: An Inadequate Safety Valve (OEI-01-00-00180; 04/01)
- Medicare Reimbursement of Prescription Drugs (OEI-03-00-00310; 1/01)
- AIDS Drug Assistance Program Cost Containment Strategies (OEI-05-99-00610; 9/00)
- Medicare Reimbursement of End Stage Renal Disease Drugs (OEI-03-00-00020; 6/00)
- Medicare Reimbursement of Albuterol (OEI-03-00-00311; 6/00)
- Medicare Licensing Requirements for Prescription Drug Suppliers (OEI-07-98-00460; 5/99)
- FDA Warning Letters: Trends and Perspectives (OEI-09-97-00380; 2/99)
- FDA Warning Letters: Timeliness And Effectiveness (OEI-09-97-00381; 2/99)
- Excessive Medicare Payments for Prescription Drugs (OEI-03-97-00290; 12/97)
- Comparing Drug Reimbursement: Medicare and Department of Veterans Affairs (OEI-03-97-00293; 11/98)
- The Impact of High-Priced Generic Drugs on Medicare and Medicaid (OEI-03-97-00510; 8/98)
- Prescription Drug Use In Nursing Homes - Report 1 - An Introduction Based on Texas (OEI-06-96-00080; 11/97)
- Prescription Drug Use In Nursing Homes - Report 2 - An Inside View by Consultant Pharmacists (OEI-06-96-00081; 11/97)
- Prescription Drug Use In Nursing Homes - Report 3 - A Pharmaceutical Review and Inspection Recommendations (OEI-06-96-00082; 11/97)
- Questionable Practices Involving Nebulizer Drug Therapy (OEI-03-94-00391; 3/97)
- Payments for Prescription Drugs Used with Nebulizers (OEI-03-94-00390; 2/96)
- A Comparison of Albuterol Sulfate Prices (OEI-03-94-00392; 6/96)
- Suppliers' Acquisition Costs for Albuterol Sulfate (OEI-03-94-00393; 6/96)
- Appropriateness of Medicare Prescription Drug Allowances (OEI-03-95-00420; 5/96)
- Postmarketing Studies of Prescription Drugs (OEI-03-94-00760; 5/96)
- Medicaid Payments for Less-Than-Effective Drugs (OEI-03-94-00090; 8/94)
- Medicaid Program Savings Through the Use of Therapeutically Equivalent Drugs (OEI-03-94-00080; 7/94)
- Multiple Copy Prescription Programs: State Experiences (OEI-12-91-00490; 6/92)
- Comparison of Reimbursement Prices for Multiple-Source Prescription Drugs in the United States and Canada (OEI-03-91-00470; 8/91)
- Strategies to Reduce Medicaid Drug Expenditures (OEI-12-90-00800; 3/91)
- Reducing Medication Problems of the Elderly (OEI-04-89-89122; 11/90)
- Medication Regimens: Causes of Non-Compliance (OEI-04-89-89121; 6/90)
- Rural Georgia Pharmacy Closures (OAI-04-90-00990; 12/89)
- Medicare Drug Utilization Review (OAI-01-88-00980; 5/89)
- Prescription Drug Promotion Involving Payments and Gifts: Physicians' Perspectives (OEI-01-90-00481; 7/92)
- Prescription Drug Advertisements in Medical Journals (OEI-01-90-00482; 6/92)
- FDA's Urgent Notices (OEI-07-94-00631; 7/96)
- OIGOversight of FDA Activities: A Summary Report (OEI-12-92-00200; 2/92)
- The FDA Prescription Drug File (OEI-03-90-02300; 11/91)
- Computer Support for FDA's Drug Registration and Listing System (OEI-03-90-02301; 11/91)
- Hospital Reporting of Adverse Drug Reactions (OEI-12-90-01000; 8/91)
- Promotion of Prescription Drugs Through Payments and Gifts (OEI-01-90-00480; 8/91)
- Symposium on Drug Utilization Review Issues - Summary Report (OEI-01-89-89010; 8/90)
- Implementing User Fees in the Food and Drug Administration: A Case Study (OEI-12-90-02020; 7/90)
- Perspectives of Drug Manufacturers: Abbreviated New Drug Applications (OEI-12-90-00770; 2/90)
- Perspectives of Drug Manufacturers: Investigational New Drug and New Drug Applications (OEI-12-90-00771; 2/90)
- Physician Drug Dispensing: An Overview of State Regulation (OAI-01-88-00590; 5/89)
Drug Utilization Review
Drug Use Review Programs
- Medicaid Drug Use Review Programs: Lessons Learned by States (OEI-01-92-00800; 5/95)
Dumping
- see also: Hospitals
- Patient Dumping After COBRA: U.S. Department of Health and Human Services Response to Complaints (OAI-12-88-00831; 12/88)
- Patient Dumping After COBRA: Assessing the Incidence and the Perspectives of Health Care Professionals (OAI-12-88-00830; 8/88)
- Inappropriate Discharges and Transfers (OAI-05-86-00050; 3/86)
- Public Health Service's Oversight of the Hill-Burton Program (OEI-05-90-00260; 8/92)
- Office for Civil Rights' Oversight of the Hill-Burton Program (OEI-05-90-00261; 8/92)
Durable Medical Equipment Regional Carriers (DMERC)
- see also: Medical Devices and Equipment
- Medicare Part B Allowances for Wound Care Supplies (OEI-03-94-00793; 6/98)
- Medicare Beneficiary Satisfaction with DMERC Services (OEI-02-96-00200; 6/97)